EAMS opinion issued for dupilumab in the treatment of children with severe atopic dermatitis
Dupilumab can be used in the treatment of children aged six to 11 years with severe atopic dermatitis that is not controlled by medicines applied as creams or ointments to the skin.
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via